retatrutide type 2 diabetes phase 2 results 2024 Eli Lilly just announced striking 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% retatrutide type 2 diabetes phase

Clinical studies show that diabetic patients using dulaglutide lose around eight to 11 pounds of their body weight, while those without type 2 diabetes using semaglutide can achieve weight loss of 15 percent or more, especially at higher doses approved for weight management. The greater efficacy of semaglutide (Ozempic) makes it the preferred choice for patients focused on significant weight loss

JAMA, 327 (6), 534-545

Packages are discreetly labeled to protect your privacy and include everything you need: Shipping times are generally quick, and tracking is provided so you can begin your journey with confidence

Getting your GLP-1 RA prescription filled at a state-licensed pharmacy that dispenses an FDA-approved product is safest

Do not inject into the same place twice in a row

My Protocol: Started at 2mg weekly, increased by 2mg every 4 weeks until reaching 8mg